Literature DB >> 10440874

Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth.

R Delsite1, D Djakiew.   

Abstract

BACKGROUND: Nerve growth factor (NGF) immunoreactive proteins derived from human prostatic stromal cells (hPS) have been implicated in the paracrine regulation of prostate epithelial cell growth. However, mature NGFbeta does not appear to be expressed by these cells. In order to determine whether NGF precursors are expressed by these cells, we investigated the potential processing and expression of precursor forms of NGF by human prostatic stromal cells, and examined the effects of NGF precursor moieties along with the other members of the neurotrophin family of gene products on soft agar colony formation of prostate epithelial cells.
METHODS: Specific antibodies to the peptide domains defined as N4 and L38, and the NGFbeta moiety of prepro-NGF, were used in immunoblot assays to characterize the molecular weight forms of precursor NGF secreted by human prostatic stromal cells. The potential processing of NGF precursors with two enzymes, NGFgamma and trypsin, was performed by incubation with stromal cell secretory protein containing precursor NGF. The selective effects of the N4, L38, and NGFbeta peptide domains of precursor NGF, along with the remaining members of the neurotrophin family, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5), were examined for their ability to stimulate growth of prostate tumor epithelial cells in an assay of soft agar colony formation.
RESULTS: Immunoblot analysis of stromal cell secretory protein identified NGF precursors of 35 kDa and 27 kDa, along with the partially processed 22-kDa form of pro-NGF, whereas mature NGFbeta was not observed. Treatment of precursor NGF with NGFgamma and trypsin did not produce the large intermediate forms of pro-NGF, although these two enzymes did appear to cleave the N-terminal peptide from NGFbeta. Of the N4, L38, and NGFbeta peptide domains of precursor NGF, only NGFbeta significantly stimulated the anchorage-independent growth of TSU-pr1 prostate epithelial cells in soft agar. The other members of the neurotrophin family of gene products had no effect on the anchorage-independent growth of prostate tumor cells.
CONCLUSIONS: Human prostate stromal cells secrete the 35-kDa and 27-kDa precursor forms of NGF arising from alternate start sites, and the partially processed 22-kDa form of pro-NGF. Whereas the N4, L38, and NGFbeta peptide domains present within pro-NGF were previously shown to induce phosphorylation of the high-affinity NGF receptor, tropomyosin receptor kinase (Trk), only the NGFbeta moiety was able to stimulate anchorage-independent growth of prostate tumor cells. Likewise, the other neurotrophin family members did not stimulate anchorage-independent growth of prostate tumor cells. Hence, it would appear that NGF may be the predominant neurotrophic growth factor for prostate growth, albeit via precursor forms of NGF, and that its effect appears to be selectively mediated via the NGFbeta moiety of these NGF precursors. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440874     DOI: 10.1002/(sici)1097-0045(19990915)41:1<39::aid-pros6>3.0.co;2-e

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  12 in total

1.  Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors.

Authors:  Raheleh Masoudi; Maria S Ioannou; Michael D Coughlin; Promila Pagadala; Kenneth E Neet; Oliver Clewes; Shelley J Allen; David Dawbarn; Margaret Fahnestock
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

2.  Human tryptase cleaves pro-nerve growth factor (pro-NGF): hints of local, mast cell-dependent regulation of NGF/pro-NGF action.

Authors:  Katrin Spinnler; Thomas Fröhlich; Georg J Arnold; Lars Kunz; Artur Mayerhofer
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

3.  Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness.

Authors:  Michael A Liss; Adam Gordon; Blanca Morales; Kathryn Osann; Douglas Skarecky; Achim Lusch; Frank Zaldivar; Thomas E Ahlering
Journal:  Urol Oncol       Date:  2014-04-29       Impact factor: 3.498

Review 4.  NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Authors:  Ralph A Bradshaw; Jay Pundavela; Jordane Biarc; Robert J Chalkley; A L Burlingame; Hubert Hondermarck
Journal:  Adv Biol Regul       Date:  2014-11-20

5.  Pro-NGF, sortilin, and p75NTR: potential mediators of injury-induced apoptosis in the mouse dorsal root ganglion.

Authors:  Melinda G Arnett; Janelle M Ryals; Douglas E Wright
Journal:  Brain Res       Date:  2007-10-26       Impact factor: 3.252

6.  The expression of neurotrophins and their receptors in the prenatal and adult human testis: evidence for functions in Leydig cells.

Authors:  Dieter Müller; Michail S Davidoff; Oliver Bargheer; Hans-J Paust; Wolfgang Pusch; Yvetta Koeva; Davor Jezek; Adolf F Holstein; Ralf Middendorff
Journal:  Histochem Cell Biol       Date:  2006-02-07       Impact factor: 4.304

Review 7.  ProNGF and Neurodegeneration in Alzheimer's Disease.

Authors:  Margaret Fahnestock; Arman Shekari
Journal:  Front Neurosci       Date:  2019-02-22       Impact factor: 4.677

8.  Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells.

Authors:  Marzia Di Donato; Gustavo Cernera; Antimo Migliaccio; Gabriella Castoria
Journal:  Cancers (Basel)       Date:  2019-06-06       Impact factor: 6.639

9.  Nerve growth factor enhances voltage-gated Na+ channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell line.

Authors:  William J Brackenbury; Mustafa B A Djamgoz
Journal:  J Cell Physiol       Date:  2007-03       Impact factor: 6.384

10.  Nerve growth factor in cancer cell death and survival.

Authors:  Niamh H Molloy; Danielle E Read; Adrienne M Gorman
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.